Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 4
2009 2
2010 4
2011 6
2012 6
2013 9
2014 4
2015 9
2016 5
2017 6
2018 6
2019 6
2020 3
2021 9
2022 9
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic Tools for Onchocerciasis Elimination Programs.
Vlaminck J, Fischer PU, Weil GJ. Vlaminck J, et al. Among authors: fischer pu. Trends Parasitol. 2015 Nov;31(11):571-582. doi: 10.1016/j.pt.2015.06.007. Epub 2015 Oct 11. Trends Parasitol. 2015. PMID: 26458784 Review.
Aspartyl Protease Inhibitors as Anti-Filarial Drugs.
Beld L, Jung H, Bulman CA, Rosa BA, Fischer PU, Janetka JW, Lustigman S, Sakanari JA, Mitreva M. Beld L, et al. Among authors: fischer pu. Pathogens. 2022 Jun 18;11(6):707. doi: 10.3390/pathogens11060707. Pathogens. 2022. PMID: 35745561 Free PMC article.
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.
Bjerum CM, Koudou BG, Ouattara AF, Lew D, Goss CW, Gabo PT, King CL, Fischer PU, Weil GJ, Budge PJ. Bjerum CM, et al. Among authors: fischer pu. PLoS Negl Trop Dis. 2023 Sep 18;17(9):e0011633. doi: 10.1371/journal.pntd.0011633. eCollection 2023 Sep. PLoS Negl Trop Dis. 2023. PMID: 37721964 Free PMC article. Clinical Trial.
A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
Opoku NO, Doe F, Dubben B, Fetcho N, Fischer K, Fischer PU, Gordor S, Goss CW, Gyasi ME, Hoerauf A, Hong AR, Kanza E, King CL, Laryea R, Lew D, Seidu MA, Weil GJ. Opoku NO, et al. Among authors: fischer pu. PLoS Negl Trop Dis. 2023 May 19;17(5):e0011365. doi: 10.1371/journal.pntd.0011365. eCollection 2023 May. PLoS Negl Trop Dis. 2023. PMID: 37205721 Free PMC article. Clinical Trial.
93 results